Research Programs

Thanks to the tools of molecular biology in general and genomics specifically, today we know more about the intricacies of cellular processes and what can go wrong to cause cancer. Investigators continue to delineate signaling pathways driving cancer development, growth, and metastasis – information which may help researchers pinpoint potential targets for novel therapies. NYU Cancer Institute investigators are at the forefront of these lines of inquiry, contributing to knowledge that may someday help people with cancer not just here in New York City, but all over the world.

Our research programs are organized as scientific research programs, which tend to focus on the fundamental biology of cancer in general, and disease-specific research programs centered on individual types of cancer, such as breast or lung cancer.

For a listing of clinical trials that are currently accruing patients, search the online clinical trials database 

Breast Cancer

Breast cancer research to improve screening, diagnosis, and treatment for women: prevention studies, research, transitional research, clinical trials.

Cancer Immunology

Research toward developing treatments for neoplasms arising from lymphoid and myeloid system cells, understanding the biology of tumor rejection, promoting tumor immunotherapy.

Environmental & Molecular Carcinogenesis

Cancer research for the study and prevention of environmental chemical and physical carcinogenesis

Genitourinary Cancer

Research of genitourinary cancer (prostate and bladder cancer): diagnosis and testing methods, stem cell research, genetics, animal models, improved chemopreventive agents and cancer treatment methods.

Growth Control

Bench research and translational research to understand the neoplastic process and develop improved and targeted cancer drugs.

Melanoma

The NYUCI Melanoma Research Program focuses its research efforts on the pathogenesis, diagnosis, and treatment of melanoma.

Stem Cell Biology

Investigations into the biology of animal stem cells to create targeted treatment methods for human cancer.